Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Surgical strategies for non-functioning pancreatic neuroendocrine tumours.

Kim MJ, Choi DW, Choi SH, Heo JS, Park HJ, Choi KK, Jang KT, Sung JY.

Br J Surg. 2012 Nov;99(11):1562-8. doi: 10.1002/bjs.8892.

PMID:
23027073
[PubMed - indexed for MEDLINE]
2.

Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experience.

Ito H, Abramson M, Ito K, Swanson E, Cho N, Ruan DT, Swanson RS, Whang EE.

J Gastrointest Surg. 2010 May;14(5):891-8. doi: 10.1007/s11605-010-1173-3. Epub 2010 Mar 12.

PMID:
20224984
[PubMed - indexed for MEDLINE]
3.

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.

Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.

J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2. Epub 2009 May 6.

PMID:
19418101
[PubMed - indexed for MEDLINE]
4.

Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs).

Hashim YM, Trinkaus KM, Linehan DC, Strasberg SS, Fields RC, Cao D, Hawkins WG.

Ann Surg. 2014 Feb;259(2):197-203. doi: 10.1097/SLA.0000000000000348.

PMID:
24253141
[PubMed - indexed for MEDLINE]
5.

Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.

Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT.

Arch Surg. 2003 Aug;138(8):859-66.

PMID:
12912744
[PubMed - indexed for MEDLINE]
6.

Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production.

Tsutsumi K, Ohtsuka T, Mori Y, Fujino M, Yasui T, Aishima S, Takahata S, Nakamura M, Ito T, Tanaka M.

J Gastroenterol. 2012 Jun;47(6):678-85. doi: 10.1007/s00535-012-0540-0. Epub 2012 Feb 17.

PMID:
22350698
[PubMed - indexed for MEDLINE]
7.

Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.

Touboul E, Buffat L, Belkacémi Y, Lefranc JP, Uzan S, Lhuillier P, Faivre C, Huart J, Lotz JP, Antoine M, Pène F, Blondon J, Izrael V, Laugier A, Schlienger M, Housset M.

Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):25-38.

PMID:
9989511
[PubMed - indexed for MEDLINE]
8.

Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas.

Fischer L, Kleeff J, Esposito I, Hinz U, Zimmermann A, Friess H, Büchler MW.

Br J Surg. 2008 May;95(5):627-35. doi: 10.1002/bjs.6051.

PMID:
18306152
[PubMed - indexed for MEDLINE]
9.

Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?

Fernández-Cruz L, Blanco L, Cosa R, Rendón H.

World J Surg. 2008 May;32(5):904-17. doi: 10.1007/s00268-008-9467-2.

PMID:
18264824
[PubMed - indexed for MEDLINE]
10.

Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections.

Boninsegna L, Panzuto F, Partelli S, Capelli P, Delle Fave G, Bettini R, Pederzoli P, Scarpa A, Falconi M.

Eur J Cancer. 2012 Jul;48(11):1608-15. doi: 10.1016/j.ejca.2011.10.030. Epub 2011 Nov 28.

PMID:
22129889
[PubMed - indexed for MEDLINE]
11.

Extended surgery for advanced pancreatic endocrine tumours.

Kleine M, Schrem H, Vondran FW, Krech T, Klempnauer J, Bektas H.

Br J Surg. 2012 Jan;99(1):88-94. doi: 10.1002/bjs.7681. Epub 2011 Aug 30.

PMID:
22135173
[PubMed - indexed for MEDLINE]
12.

Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable?

Teh SH, Deveney C, Sheppard BC.

Am J Surg. 2007 May;193(5):610-3; discussion 613.

PMID:
17434366
[PubMed - indexed for MEDLINE]
13.

Outcome after laparoscopic enucleation for non-functional neuroendocrine pancreatic tumours.

Fernández-Cruz L, Molina V, Vallejos R, Jiménez Chavarria E, López-Boado MA, Ferrer J.

HPB (Oxford). 2012 Mar;14(3):171-6. doi: 10.1111/j.1477-2574.2011.00422.x. Epub 2012 Jan 9.

PMID:
22321035
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.

Matthews BD, Heniford BT, Reardon PR, Brunicardi FC, Greene FL.

Am Surg. 2000 Dec;66(12):1116-22; discussion 1122-3.

PMID:
11149582
[PubMed - indexed for MEDLINE]
15.

Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.

Benassai G, Mastrorilli M, Mosella F, Mosella G.

J Exp Clin Cancer Res. 1999 Mar;18(1):23-8.

PMID:
10374672
[PubMed - indexed for MEDLINE]
16.

Pancreatic neuroendocrine tumors: presentation, management, and outcomes.

Nissen NN, Kim AS, Yu R, Wolin EM, Friedman ML, Lo SK, Wachsman AM, Colquhoun SD.

Am Surg. 2009 Oct;75(10):1025-9.

PMID:
19886158
[PubMed - indexed for MEDLINE]
17.

Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.

Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Büchler MW.

Br J Surg. 2004 May;91(5):586-94.

PMID:
15122610
[PubMed - indexed for MEDLINE]
18.

Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis.

Poultsides GA, Huang LC, Chen Y, Visser BC, Pai RK, Jeffrey RB, Park WG, Chen AM, Kunz PL, Fisher GA, Norton JA.

Ann Surg Oncol. 2012 Jul;19(7):2295-303. doi: 10.1245/s10434-012-2305-7. Epub 2012 Mar 7.

PMID:
22396008
[PubMed - indexed for MEDLINE]
19.

Surgical management of primary retroperitoneal sarcoma.

Strauss DC, Hayes AJ, Thway K, Moskovic EC, Fisher C, Thomas JM.

Br J Surg. 2010 May;97(5):698-706. doi: 10.1002/bjs.6994.

PMID:
20306527
[PubMed - indexed for MEDLINE]
20.

The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma.

Shimada K, Sakamoto Y, Sano T, Kosuge T.

J Am Coll Surg. 2006 Sep;203(3):345-52. Epub 2006 Jul 21.

PMID:
16931307
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk